Effects of acute moderate hypoxemia on kinetics of metoclopramide and its metabolites in chronically instrumented sheep

Archives of Pharmacal Research

Volumn 25, Issue 5, 2002, Pages 709-717

  Kim, John ^a,b   Riggs, K Wayne ^a   Rurak, Dan W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b LG Chemical Ltd   (South Korea)

Author keywords

GC MS; Hypoxemia; Metoclopromide; Pharmacokinetics

Indexed keywords

METOCLOPRAMIDE;

ACUTE DISEASE; ANIMAL; ARTICLE; COMPARATIVE STUDY; FEMALE; HYPOXEMIA; METABOLIC CLEARANCE RATE; METABOLISM; SHEEP;

ACUTE DISEASE; ANIMALS; ANOXEMIA; FEMALE; METABOLIC CLEARANCE RATE; METOCLOPRAMIDE; SHEEP;

EID: 0036780801     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02976949     Document Type: Article

References (37)

1. Audibert, G., Saunier, C., du Souich, P., In vivo and in vitro effect of cimetidine, inflammation, and hypoxia on propofol kinetics. Drug Metabol. Disp., 21, 7-12 (1992).
2. Babini, R., du Souich, P., Furosemide pharmacokinetics: effects of respiratory and acid-base disturbances. J. Pharmacol. Exp. Ther., 237, 623-628 (1986).
3. Bargetzi, M., Aoyama, T., Gonzales, F., Meyer, U., Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin. Pharmacol. Ther., 46, 521-527 (1989).
4. Bateman, D.N., Kahn, C., Davies, D.S., The pharmacokinetics of metoclopramide in human with observation in the dog. Brit. J. Clin. Pharmacol., 9, 327-377 (1980).
5. Baum, D., Porte, D., Stress hyperglycemia and the adrenergic regulation of pancreatic hormones in hypoxia. Metabolism 29 (Suppl 1), 1176-1185 (1980).
6. Brass, C.A., Narciso, J., Gollan, J.L., Enhanced activity of the free radical producing enzyme xanthine oxidase in hypoxemic rat liver: Regulation and pathological significance. J. Clin. Invest., 87, 424-431 (1991).
7. Colice, G., Yen, S., Ramirez, G., Dietz, J., Ou, L., Acute hypoxia-induced diuresis in rats. Aviation Space Environ. Med., 62, 551-554 (1991).
8. Cowan, D.A., Huizing, G., Beckett, A.H., Identification of four new metabolic products of metoclopramide using mass spectrometry. Xenobiotica, 6, 650-616 (1976).
9. Desmond, P.V., Watson, K.J., Metoclopramide - A Review. Med. J. Australia, 144, 366-368 (1986).
10. Erickson, R.R., Yu-Drent, P., Holtzman, J., The kinetics of ethylmorphine N-demethylation in isolated hepatocytes: the effect of drug transport and oxygen concentration. J. Pharmacol. Exp. Ther., 220, 35-38 (1982).
11. Gleed, R.D., Poore, R., Modification of maternal and fetal oxygenation with the use of tracheal gas infusion. Am. J. Obst. Gynecol., 155, 429-435 (1986).
12. Harrington, R. A., Hamiltion, C. W., Brogden, R., Linkewich, J., Romankiewcz J., Hell, R., Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs, 25, 451-494 (1983).
13. Hill, K. J., Lumbers, E.R., Renal function in adult and fetal sheep. J. Develop. Physiol., 10, 149 (1988)
14. Holtzman, J., Gander, J., Erickson, R., The effect of NADH and low oxygen pressure on the hepatic microsomal ethylmorphine N-demethylase activity of the male rat. J. Biol. Chem., 258, 5400-5404 (1983).
15. Huckabee, W.E., Relationship of pyruvate and lactate during anaerobic metabolism. I. Effects of infusion of pyruvate or glucose and of hyperventilation. J. Clin. Invest., 37, 244-254 (1958).
16. Jones, D., Hypoxia and drug metabolism. Biochem. Pharmacol., 30, 1019-1023 (1981).
17. Jurgens, G, Christensen, H. R., Brosen, K., et al., Acute hypoxia and chromosome P450-mediated drug metabolism in humans. Clinc. Pharmacol. Ther., 71, 214-220 (2002).
18. Kapil, R., Axelson, J.E., Ongley, R., Price, J., Nonlinear bioavailablity of metoclopramide in rat: evidence forsaturable fist-pass metabolism. J. Pharm. Sci., 73, 215-216 (1984).
19. Kennedy, J. M., Riji, A. M., Effect of surgery on the pharmacokinetic parameters of drugs. Clin. Pharmacokinet., 35, 292-312 (1998).
20. Letarte, L., du Souich, P., Influence of hypercapnia and/or hypoxemia and metabolic acidosis in theophylline kinetics in the conscious rabbit. Am. Rev. Respir. Dis., 129, 762-766 (1984).
21. M. Roland, T.N. Tozer: Clinical Pharmacokinetics. 2nd ed. Lea & Febiger, Philadelphia, PA (1989).
22. Marleau, S., Ong, H., Gariepy, L., du Souich, P., Lidocaine and Indocyanine kinetics: effects of hypoxemia and/or hypercapnia. J. Pharmacol. Exp., Ther. 242, 338-343 (1987).
23. Mathie, R.T., Blumgart, L., Effect of denervation on the hepatic haemodynamic response to hypercapnia and hypoxia in the dog. Pfluger Archiv., 397, 152-157 (1983).
24. Ng, C. Y., Ghabrial, H., Morgan, D. J., Ching, M. S. et al., Impaired elimination of propanolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity. Drug Metab. Disp., 28, 1217-1221 (2000).
25. Proulx, M., du Souich, P., Influence of hypoxia induced oxidative stress on cytochrome P-450. Eur. J. Pharmacol., 183, 1361 (1990).
26. Riggs, K.W., Szeitz, A., Rurak, D.W., Mutlib, A.E., Abbott, F.S., Axelson, J.E., Analysis of metoclopramide and two of its metabolites using a sensitive and selective gas chromatographic assay with mass selective detection. J. Chromatogr. B Biomed. Appl., 660, 315-325 (1994).
27. Rizza, R.A., Cryer, P.E., Haymond, M., Gerich, J., Adrenergic mechanism for the effects of epinephrine on glucose production and clearance in man. J. Clin. Invest. 65, 682-689 (1980).
28. Saunier, C., du Souich, P., Theophylline disposition during acute and chronic hypoxia in the conscious dog. Res. Comm. Chem. Path. Pharmacol., 57, 291-299 (1987).
29. du Souich, P., Clozel, P., Saunier, C., Ong, H., Hartemann, D., Garcia-Carmona, T., Sadoul, P., Influence of hypoxemia and respiratory acidosis on the plasma kinetics and tissue distribution of digoxin in the conscious dog. Can. J. Physiol. Pharmacol., 63,72-77 (1985).
30. du Souich, P., Courteau, H., Influence of hypercapnia and(or) hypoxemia and metabolic acidosis on sulfamethazine kinetics in the conscious rabbit. Can. J. Physiol. Pharmacol., 62, 1170-1177 (1984).
31. du Souich, P., Saunier, C., Hartemann, D., Allan, M., Effect of acute and chronic hypoxia on the kinetics of lidocaine and its metabolite and on regional blood flow. Pulmonary Pharmacol., 5, 9-16 (1992).
32. du Souich, P., Varin, F., Courteau, H., Effect of hypercapnia and/or hypoxemia and metabolic acidosis on the kinetics and concentrations of phenytoin in the cerebrospinal fluid of conscious rabbits. Neuropharmacol., 25, 857-862 (1986).
33. Teng, T., Bruce, R.B., Dunning, L.K., Metoclopramide metabolism and determination by high-pressure liquid chromatography. J. Pharm. Sci., 66, 1615-1617 (1977).
34. Tsuru, M., Erickson, R.R., Holtzman, J.: The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats. J. Pharmacol. Exp. Ther., 222, 658-661 (1982).
35. W.F. Ganong: Review of Medical Physiology. Lange Medical Publications, Los Altos, CA (1985).
36. Walker B.R., Diuretic response to acute hypoxia in the conscious dog. Am. J. Physiol., 243, F440-446 (1982).
37. Zborowska-Sluis, D. T., Dossetor, J. B., Hyperlactatemia of hyperventilation. J. Appl. Physiol., 22, 746-755, (1967).